Molecule Information
General Information of the Molecule (ID: Mol00078)
| Name |
Glutathione S-transferase P (GSTP1)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
GST class-pi; GSTP1-1; FAEES3; GST3
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
GSTP1
|
||||
| Gene ID | |||||
| Location |
chr11:67583742-67586656[+]
|
||||
| Sequence |
MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGD
LTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYV KALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAY VGRLSARPKLKAFLASPEYVNLPINGNGKQ Click to Show/Hide
|
||||
| 3D-structure |
|
||||
| Function |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2). Participates in the formation of novel hepoxilin regioisomers. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule with Structure Alteration
Drug Resistance Data Categorized by Drug
Investigative Drug(s)
1 drug(s) in total
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | |||||||||||||
|
|
|||||||||||||
| Disease Class: Colorectal cancer [ICD-11: 2B91.1] | [1] | ||||||||||||
| Sensitive Disease | Colorectal cancer [ICD-11: 2B91.1] | ||||||||||||
| Sensitive Drug | Folfox protocol | ||||||||||||
| Molecule Alteration | Missense mutation | p.I105V (c.313A>G) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 1.40 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 1.80 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
M
M
P
P
P
P
Y
Y
T
T
V
V
V
V
Y
Y
F
F
10
|
P
P
V
V
R
R
G
G
R
R
C
C
A
A
A
A
L
L
R
R
20
|
M
M
L
L
L
L
A
A
D
D
Q
Q
G
G
Q
Q
S
S
W
W
30
|
K
K
E
E
E
E
V
V
V
V
T
T
V
V
E
E
T
T
W
W
40
|
Q
Q
E
E
G
G
S
S
L
L
K
K
A
A
S
S
C
C
L
L
50
|
Y
Y
G
G
Q
Q
L
L
P
P
K
K
F
F
Q
Q
D
D
G
G
60
|
D
D
L
L
T
T
L
L
Y
Y
Q
Q
S
S
N
N
T
T
I
I
70
|
L
L
R
R
H
H
L
L
G
G
R
R
T
T
L
L
G
G
L
L
80
|
Y
Y
G
G
K
K
D
D
Q
Q
Q
Q
E
E
A
A
A
A
L
L
90
|
V
V
D
D
M
M
V
V
N
N
D
D
G
G
V
V
E
E
D
D
100
|
L
L
R
R
C
C
K
K
Y
Y
I
V
S
S
L
L
I
I
Y
Y
110
|
T
T
N
N
Y
Y
E
E
A
A
G
G
K
K
D
D
D
D
Y
Y
120
|
V
V
K
K
A
A
L
L
P
P
G
G
Q
Q
L
L
K
K
P
P
130
|
F
F
E
E
T
T
L
L
L
L
S
S
Q
Q
N
N
Q
Q
G
G
140
|
G
G
K
K
T
T
F
F
I
I
V
V
G
G
D
D
Q
Q
I
I
150
|
S
S
F
F
A
A
D
D
Y
Y
N
N
L
L
L
L
D
D
L
L
160
|
L
L
L
L
I
I
H
H
E
E
V
V
L
L
A
A
P
P
G
G
170
|
C
C
L
L
D
D
A
A
F
F
P
P
L
L
L
L
S
S
A
A
180
|
Y
Y
V
V
G
G
R
R
L
L
S
S
A
A
R
R
P
P
K
K
190
|
L
L
K
K
A
A
F
F
L
L
A
A
S
S
P
P
E
E
Y
Y
200
|
V
V
N
N
L
L
P
P
I
I
N
N
G
G
N
N
G
G
K
K
210
|
Q
Q
|
|||||||||||||
| Experimental Note | Identified from the Human Clinical Data | ||||||||||||
| In Vitro Model | Human colorectal carcinoma tissue | N.A. | |||||||||||
| Mechanism Description | The missense mutation p.I105V (c.313A>G) in gene GSTP1 cause the sensitivity of Folfox Protocol by drug inactivation by structure modification | ||||||||||||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
